Croda International/£CRDA

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Croda International

Founded in 1925, Croda International Plc is a UK-based speciality chemicals company recognized globally for its innovative approach to delivering specialized chemical solutions across a broad range of industries including consumer care and life sciences. Operating within the basic materials sector, Croda develops, manufactures, and markets a wide array of specialty chemicals used in everything from cosmetics and pharmaceuticals to lubricants and plastics. Over the decades, Croda has committed to sustainability and innovation, driving its growth and solidifying its position as in the industry.

Ticker

£CRDA
Sector

Primary listing

LSE

Industry

Chemicals

Employees

6,027

ISIN

GB00BJFFLV09

CRDA Metrics

BasicAdvanced
£4.2B
26.34
£1.14
0.76
£1.10
3.68%

What the Analysts think about CRDA

Analyst ratings (Buy, Hold, Sell) for Croda International stock.

Bulls say / Bears say

Croda's opening of a new lipids manufacturing facility in Pennsylvania in March 2025 is expected to enhance production capacity and meet growing demand in the pharmaceutical sector. (croda.com)
The Consumer Care segment showed resilience with a 7% increase in sales in 2024, indicating strong demand for Croda's products in this sector. (croda.com)
Croda's strategic divestment of its Performance Technologies and Industrial Chemicals businesses has streamlined operations, focusing on higher-margin sectors like Consumer Care and Life Sciences. (croda.com)
Croda anticipates a decline in profit and profit margins for 2024 due to ongoing customer destocking and subdued demand in its Crop Protection and Industrial Specialties segments. (reuters.com)
The Life Sciences segment experienced a 14% decrease in sales in 2024, primarily due to reduced demand for COVID-19 lipids, impacting overall revenue. (croda.com)
Croda's adjusted operating margin declined to 17.2% in 2024 from 18.9% in 2023, reflecting challenges in maintaining profitability amid changing market conditions. (croda.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.

CRDA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CRDA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £CRDA

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs